Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 136, Issue 1, 2013, Pages 183-186

  Ito, Nobuaki ^a   Findlay, David M ^a   Anderson, Paul H ^b   Bonewald, Lynda F ^c   Atkins, Gerald J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

25D IDG SW3 Osteocyte GALNT3; Phosphate FGF23 1

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; DENTIN MATRIX PROTEIN 1; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATE; PROTEINASE;

ANIMAL CELL; GENE CONTROL; GENE EXPRESSION; METABOLISM; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PHENOTYPE; REVIEW; UPREGULATION; VITAMIN D METABOLISM; X CHROMOSOME;

EID: 84881175225     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.09.029     Document Type: Review

References (21)

1. R. Kitazawa, S. Kitazawa, Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter, Biochemical and Biophysical Research Communications 290 (2) (2002) 650-655.
2. G.J. Atkins, D.M. Findlay, Osteocyte regulation of bone mineral: a little give and take, Osteoporosis International 23 (8) (2012) 2067-2079.
3. T. Shimada, H. Hasegawa, Y. Yamazaki, T. Muto, R. Hino, Y. Takeuchi, T. Fujita, K. Nakahara, S. Fukumoto, T. Yamashita, FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis, Journal of Bone and Mineral Research 19 (3) (2004) 429-435.
4. J.Q. Feng, L.M. Ward, S. Liu, Y. Lu, Y. Xie, B. Yuan, X. Yu, F. Rauch, S.I. Davis, S. Zhang, H. Rios, M.K. Drezner, L.D. Quarles, L.F. Bonewald, K.E. White, Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism, Nature Genetics 38 (11) (2006) 1310-1315.
5. B. Lorenz-Depiereux, M. Bastepe, A. Benet-Pages, M. Amyere, J. Wagenstaller, U. Muller-Barth, K. Badenhoop, S.M. Kaiser, R.S. Rittmaster, A.H. Shlossberg, J.L. Olivares, C. Loris, F.J. Ramos, F. Glorieux, M. Vikkula, H. Juppner, T.M. Strom, DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis, Nature Genetics 38 (11) (2006) 1248-1250.
6. F. Francis, S. Hennig, B. Korn, R. Reinhardt, D. de Jong, A. Poustka, H. Lehrach, P.S. Rowe, J.N. Goulding, T. Summerfield, R.C. Mountford, A.P. Read, E. Popowska, K.E. Davies, J.L. O'Riordan, M.J. Econs, T. Nesbitt, M.K. Drezner, C. Oudet, S. Pannetier, A. Hanauer, T.M. Strom, A. Meindl, B. Lorenz, M. Cagnoli, K.L. Mohnike, J. Murken, T. Meitinger, A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP consortium, Nature Genetics 11 (2) (1995) 130-136.
7. Y. Yamazaki, R. Okazaki, M. Shibata, Y. Hasegawa, K. Satoh, T. Tajima, Y. Takeuchi, T. Fujita, K. Nakahara, T. Yamashita, S. Fukumoto, Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia, Journal of Clinical Endocrinology and Metabolism 87 (11) (2002) 4957-4960.
8. V. Levy-Litan, E. Hershkovitz, L. Avizov, N. Leventhal, D. Bercovich, V. Chalifa-Caspi, E. Manor, S. Buriakovsky, Y. Hadad, J. Goding, R. Parvari, Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene, American Journal of Human Genetics 86 (2) (2010) 273-278.
9. B. Lorenz-Depiereux, D. Schnabel, D. Tiosano, G. Hausler, T.M. Strom, Lossof- function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets, American Journal of Human Genetics 86 (2) (2010) 267-272.
10. ADHR Consortium, Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23, Nature Genetics 26 (3) (2000) 345-348.
11. V. David, A. Martin, A.M. Hedge, M.K. Drezner, P.S. Rowe, ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate, American Journal of Physiology - Renal Physiology 300 (3) (2011) F783-F791.
12. T. Shimada, Y. Yamazaki, M. Takahashi, H. Hasegawa, I. Urakawa, T. Oshima, K. Ono, M. Kakitani, K. Tomizuka, T. Fujita, S. Fukumoto, T. Yamashita, Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism, American Journal of Physiology - Renal Physiology 289 (5) (2005) F1088-F1095.
13. F. Perwad, N. Azam, M.Y. Zhang, T. Yamashita, H.S. Tenenhouse, A.A. Portale, Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice, Endocrinology 146 (12) (2005) 5358-5364.
14. H. Saito, A. Maeda, S. Ohtomo, M. Hirata, K. Kusano, S. Kato, E. Ogata, H. Segawa, K. Miyamoto, N. Fukushima, Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo, Journal of Biological Chemistry 280 (4) (2005) 2543-2549.
15. S.L. Ferrari, J.P. Bonjour, R. Rizzoli, Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men, Journal of Clinical Endocrinology and Metabolism 90 (3) (2005) 1519-1524.
16. R. Yamamoto, T. Minamizaki, Y. Yoshiko, H. Yoshioka, K. Tanne, J.E. Aubin, N. Maeda, 1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro, Journal of Endocrinology 206 (3) (2010) 279-286.
17. S.M. Woo, J. Rosser, V. Dusevich, I. Kalajzic, L.F. Bonewald, Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo, Journal of Bone and Mineral Research 26 (11) (2011) 2634-2646.
18. G.J. Atkins, P.S. Rowe, H.P. Lim, K.J. Welldon, R. Ormsby, A.R. Wijenayaka, L. Zelenchuk, A. Evdokiou, D.M. Findlay, Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism, Journal of Bone and Mineral Research 26 (7) (2011) 1425-1436.
19. Y. Frishberg, N. Ito, C. Rinat, Y. Yamazaki, S. Feinstein, I. Urakawa, P. Navon-Elkan, R. Becker-Cohen, T. Yamashita, K. Araya, T. Igarashi, T. Fujita, S. Fukumoto, Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23, Journal of Bone and Mineral Research 22 (2) (2007) 235-242.
20. P.H. Anderson, G.J. Atkins, The skeleton as an intracrine organ for vitamin D metabolism, Molecular Aspects of Medicine 29 (6) (2008) 397-406.
21. S. Liu, W. Tang, J. Zhou, J.R. Stubbs, Q. Luo, M. Pi, L.D. Quarles, Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D, Journal of the American Society of Nephrology 17 (5) (2006) 1305-1315.